您当前的位置:首页 > 新闻中心 > 行业新闻
Specializing in early phase studies across neurodegenerative and psychiatric indications 2019年06月21日

Advanced Brain Monitoring has pioneered the use of EEG-based awake and asleep assessment technologies for pharmaceutical, medical device and academic clinical trials. With expertise across a broad range of neurological disorders, our neuroscience research team delivers streamlined EEG acquisition, secure management of data integrity, customized data analysis and worldwide clinical support. Our technologies combined with innovative evidence-based biomarker analyses with cloud-based 21 CFR compliant technology delivery platforms.


Services Offered

Clinical EEG protocol development and IRB support

Options for EEG acquisition to fit your needs:

Run studies at ABM facilities

Technology “drop shipped” to your study sites anywhere worldwide

Certification of new technicians with 6-step, single day process either on-site or via online-remote protocol

Devices are FDA-cleared

Services are HIPAA and 21 CFR Part 11 compliant including data management via a cloud based portal system

Secure, web-based portal provides centralized data management allowing for auditable analyses and timely reporting to sponsor

Ongoing data quality feedback to sites as needed

Customized quantitative data analysis

Quality and timely study reports

Awake EEG Analysis Capabilities


Quantitative EEG (QEEG): Power spectral densities at 1Hz bins or standard bands:

Delta 1-4 Hz

Theta 4-7 Hz

Alpha 8-15 Hz

Beta 16-31 Hz

Gamma 32-40+

Event related potentials (ERP)

Low resolution electromagnetic tomography (LORETA)

EEG Coherence

EEG Phase Delay

Alpha anterior/posterior gradients


分享到:

最热资讯

热门标签